Brook Byers has been a venture capital investor since 1972. He has been closely involved with more than 60 new technology-based ventures, many of which have become public companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare and biotechnology sectors. Brook was the founding president and then chairman of four biotechnology companies that were incubated in KPCB’s offices and went on to become public companies with an aggregate market value of more than US$8 billion. He currently serves on the board of directors of CardioDX, Crescendo, Elcelyx, Foundation Medicine, Oculeve, OptiMedica, Pacific Biosciences, Inc., Tethys, Veracyte and XDx, Inc.
Brook is on the Board of Trustees of Stanford University, a board member of the University of California, San Francisco, Medical Foundation and the New Schools Foundation. He is a former director of the Entrepreneurs Foundation, the Asian Art Museum in San Francisco and the Georgia Tech Advisory Board. He was also a founder of TechNet.
Raised in Atlanta, Georgia, Brook graduated with a bachelor’s degree in electrical engineering from Georgia Tech and received an M.B.A. from Stanford University.